Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV1 Infection”

1,918 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,918 results

Large-scale testing (Phase 3)Study completedNCT00013520
What this trial is testing

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,125
Early research (Phase 1)Study completedNCT00027261
What this trial is testing

Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 110
Early research (Phase 1)Study completedNCT00856154
What this trial is testing

Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HIV-Infection

Who this might be right for
HIV Infections
Statens Serum Institut 12
Not applicableNot Yet RecruitingNCT07146529
What this trial is testing

Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis

Who this might be right for
HIV SeropositivityHIV Drug ResistanceHIV Infections
ANRS, Emerging Infectious Diseases 30,060
Large-scale testing (Phase 3)Study completedNCT00002359
What this trial is testing

A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega

Who this might be right for
HIV Infections
The Immune Response Corporation 3,000
Early research (Phase 1)Study completedNCT00111605
What this trial is testing

Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 144
Not applicableStudy completedNCT00002270
What this trial is testing

A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection

Who this might be right for
HIV InfectionsLeukoencephalopathy, Progressive Multifocal
University of Miami
Not applicableStudy completedNCT04068441
What this trial is testing

Measurement for Viral Reservoir and Immune Function in HIV-1-infected Patients Under Antiretroviral Therapy

Who this might be right for
HIV-1-infection
National Taiwan University Hospital 35
Early research (Phase 1)Study completedNCT02256631
What this trial is testing

Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 83
Large-scale testing (Phase 3)Study completedNCT00552682
What this trial is testing

Pilot, Opened, Randomized Clinical Trial to Assess the Efficacy of Duloxetine in the Treatment of Fibromialgy in Patients With Infection by HIV 1+

Who this might be right for
FibromyalgiaHIV-1 Infection
Germans Trias i Pujol Hospital 10
Not applicableStudy completedNCT00034086
What this trial is testing

Study of Anti-HIV Therapy Intensification

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07384624
What this trial is testing

Combining Latency Reversing Agents to Address the HIV Reservoir

Who this might be right for
HIV (Human Immunodeficiency Virus)HIV -1 Infection
Erasmus Medical Center 30
Not applicableStudy completedNCT04266002
What this trial is testing

HIV-1 Infected Adult Subjects With HIV-associated Neurocognitive Disorders Despite Effective Antiretroviral Therapy

Who this might be right for
HIV-1-infectionHIV Associated Neurocognitive Disorder
Hôpital Franco-Britannique-Fondation Cognacq-Jay 31
Not applicableStudy completedNCT04238767
What this trial is testing

Dolutegravir in Real Life in Lesotho

Who this might be right for
HIV-1-infection
Swiss Tropical & Public Health Institute 1,433
Testing effectiveness (Phase 2)Study completedNCT00001085
What this trial is testing

141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 94
Early research (Phase 1)Study completedNCT00000864
What this trial is testing

Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableEnded earlyNCT00321438
What this trial is testing

Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus

Who this might be right for
HIV Infection
GlaxoSmithKline 150
Post-approval studies (Phase 4)Study completedNCT00449436
What this trial is testing

Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults

Who this might be right for
HIV Infections
GlaxoSmithKline 152
Early research (Phase 1)Study completedNCT00613249
What this trial is testing

A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels

Who this might be right for
HIV Infections
International Partnership for Microbicides, Inc. 36
Testing effectiveness (Phase 2)Study completedNCT00001993
What this trial is testing

Initial Phase II Efficacy and Safety Study of SC-48334 Administered in Combination With Low-Dose Zidovudine (AZT) to Symptomatic HIV-1 Infected Patients With = or > 200 to = or < 500 CD4+ Cells/mm3

Who this might be right for
HIV Infections
G D Searle 120
Load More Results